Drawing for INTEGRIUM

USPTO serial 76398828

INTEGRIUM

Reviewed by CopyMark Law Group

Reg. 2936617Status 710
Filing date
Status date
Registration date
Mar 29, 2005
Examiner
COFIELD, JULIA
Law office
TMEG LAW OFFICE 108

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with INTEGRIUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James L. Bikoff, Esq.

JAMES L BIKOFF ESQ Smith, Gambrell & Russell1055 Thomas Jefferson Street, NWSuite 400Washington, DC 20007

Goods and services

ClassDescriptionStatusFirst use
035MANAGEMENT ASSISTANCE FOR CLINICAL TRIALS OF INVESTIGATIONAL DRUGS, NAMELY, ARRANGING FOR SITES TO PERFORM CLINICAL TRIALS, ARRANGING FOR THE IMPORT, PACKAGING, SHIPPING, LABELING, AND DISTRIBUTION OF DRUGS AND OTHER INVESTIGATIONAL SUPPLIES AND EQUIPMENT TO AND FROM THE CLINICAL TRIAL SITES, ARRANGING FOR THE CENTRAL COLLECTION OF LABORATORY SPECIMENS FROM CLINICAL TRIAL SITES, MAKING ANY AND ALL FILINGS REQUIRED BY THE FOOD AND DRUG ADMINISTRATION FOR INVESTIGATIONAL NEW DRUGS AND NEW DRUG APPLICATIONS, PREPARING STATISTICAL REPORTS RESULTING FROM CLINICAL TRIALS; COOPERATIVE ADVERTISING AND MARKETING OF NEW DRUGSSECTION 8 - CANCELLEDAug 15, 2002
037REAL ESTATE SITE SELECTION, NAMELY, INSPECTING BUILDINGS AND OFFICES AS POTENTIAL SITES FOR HOSTING CLINICAL TRIALSSECTION 8 - CANCELLEDAug 15, 2002
041TRAINING CLINICAL TRIAL SITE PERSONNEL CONCERNING DRUG PROTOCOL REQUIREMENTS AND THE USE OF TESTS AND RATING SYSTEMS FOR SUCH PROTOCOL; TRAINING CLINICAL TRIAL PERSONNEL IN THE USE OF MEDICAL AND RESEARCH EQUIPMENT REQUIRED BY DRUG AND/OR DEVICE PROTOCOLS; ARRANGING MEDICAL CONFERENCES AND SYMPOSIA; PROVIDING CONTINUING MEDICAL EDUCATION TO PHYSICIANS AND OTHER HEALTH-CARE PROVIDERS AND ARRANGING AND MANAGING SPEAKERS' BUREAUS IN CONJUNCTION THEREWITH; MEDICAL MANUSCRIPT PREPARATION AND SUBMISSION; DEVELOPMENT AND PUBLICATION OF MEDICAL JOURNALSSECTION 8 - CANCELLEDAug 15, 2002
042TECHNICAL WRITING OF CLINICAL TRIAL REPORTS FOR OTHERS; DATABASE DEVELOPMENT SERVICES TO PROCESS DATA COLLECTED FROM CLINICAL TRIALS; PHARMACEUTICAL DRUG DEVELOPMENT SERVICESSECTION 8 - CANCELLEDAug 15, 2002
044PROVIDING MEDICAL MONITORING SERVICES, NAMELY, REVIEW OF TRAIL DATA REPORTS FOR SAFETY PURPOSES, AND TO DETERMINE AND ASSURE COMPLIANCE WITH CLINICAL STUDY PROTOCOL REQUIREMENTS AS WELL AS COMPLIANCE WITH GOOD CLINICAL PRACTICES AND FOOD AND DRUG ADMINISTRATION AND/OR OTHER REGULATIONS GOVERNING CLINICAL TRIALSSECTION 8 - CANCELLEDAug 15, 2002

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 30, 2015CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jan 15, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 31, 2011C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 30, 2011APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 29, 2011E815TEAS SECTION 8 & 15 RECEIVED
Mar 29, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 22, 2004ALIEASSIGNED TO LIE
Sep 21, 2004REGVLAW OFFICE REGISTRATION REVIEW COMPLETED
Sep 20, 2004ALIEASSIGNED TO LIE
Aug 18, 2004CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 2, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 29, 2003CFITCASE FILE IN TICRS
Dec 19, 2003SUPCSTATEMENT OF USE PROCESSING COMPLETE
Dec 18, 2003FAXXFAX RECEIVED
Dec 16, 2003IUAFUSE AMENDMENT FILED
Dec 16, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 23, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 3, 2003NPUBNOTICE OF PUBLICATION
Jul 24, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 3, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2003MAILPAPER RECEIVED
Sep 26, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 16, 2002DOCKASSIGNED TO EXAMINER
Apr 26, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2002MAILPAPER RECEIVED
Apr 24, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE

Frequently asked questions

Related guidance